Investigation of the potential drug-drug interactions between commonly prescribed medications in a geriatric population.
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objectives of Study
- 1.5Limitations of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Overview of Drug-Drug Interactions
- 2.2Impact of Drug-Drug Interactions on Geriatric Population
- 2.3Commonly Prescribed Medications in Geriatric Patients
- 2.4Previous Studies on Drug-Drug Interactions in Geriatric Population
- 2.5Risk Factors for Drug-Drug Interactions in Geriatric Patients
- 2.6Pharmacokinetics and Pharmacodynamics in Geriatric Population
- 2.7Strategies for Preventing Drug-Drug Interactions
- 2.8Tools and Resources for Detecting Drug-Drug Interactions
- 2.9Challenges in Assessing Drug-Drug Interactions in Geriatric Patients
- 2.10Future Trends in Studying Drug-Drug Interactions
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design
- 3.2Sampling Techniques
- 3.3Data Collection Methods
- 3.4Data Analysis Procedures
- 3.5Ethical Considerations
- 3.6Validity and Reliability
- 3.7Variables and Measurements
- 3.8Statistical Tools Used
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- Discussion of Findings
- 4.1Overview of Data Collected
- 4.2Analysis of Drug-Drug Interactions in Geriatric Population
- 4.3Comparison with Previous Studies
- 4.4Interpretation of Results
- 4.5Implications for Clinical Practice
- 4.6Recommendations for Future Research
- 4.7Limitations of the Study
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- and Summary
- 5.1Summary of Findings
- 5.2Conclusions Drawn
- 5.3Contributions to the Field of Pharmacy
- 5.4Practical Implications
- 5.5Recommendations for Practice
- 5.6Suggestions for Further Research
Project Abstract
This research project aims to investigate the potential drug-drug interactions between commonly prescribed medications in a geriatric population. The geriatric population is particularly vulnerable to adverse drug reactions due to physiological changes associated with aging, multiple comorbidities, and the concurrent use of multiple medications. Drug-drug interactions (DDIs) can result in decreased efficacy, increased toxicity, or new adverse effects, posing significant risks to the health and well-being of older adults. The study will begin with a comprehensive review of the literature to identify the most commonly prescribed medications in the geriatric population and their known potential for drug interactions. This literature review will provide a foundation for understanding the scope and significance of the problem, as well as gaps in current knowledge that warrant further investigation. The research methodology will involve a retrospective analysis of medication records from a sample of geriatric patients in a healthcare setting. By examining the medication profiles of these individuals, the study aims to identify potential drug-drug interactions based on established criteria and guidelines. Additionally, demographic and clinical data will be collected to assess the impact of patient characteristics on the risk of DDIs. The findings from the analysis will be presented and discussed in Chapter Four, highlighting the prevalence of potential drug-drug interactions, the specific medications involved, and the potential clinical implications for the geriatric population. The discussion will also explore strategies for mitigating the risks associated with DDIs, such as medication reconciliation, drug regimen reviews, and patient education. In conclusion, this research project will contribute to the body of knowledge on drug-drug interactions in the geriatric population and provide insights into the factors contributing to this issue. The study findings will have implications for healthcare providers, pharmacists, and policymakers in developing strategies to improve medication safety and optimize the quality of care for older adults. Ultimately, the goal is to enhance patient outcomes and reduce the incidence of adverse drug reactions in this vulnerable population.
Project Overview